跳至主要内容
临床试验/CTRI/2024/03/063484
CTRI/2024/03/063484尚未招募Phase 3 4

Randomised controlled clinical study to evaluate the efficacy of Vidangadi churn in prameha purvarupavastha with special reference to prediabetic subject

VD Dnyanesh Sambhaji Deshmukh1 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2024年3月11日最近更新:

试验速览

阶段
Phase 3 4
状态
尚未招募
发起方
入组人数
70
试验地点
1
主要终点
Decrease in HbA1c level

研究概览

简要总结

Ayurvedic approach in the management of Prediabetes by using vidangadi churn. improvement in Hba1c in 3 month by using  vidangadi churn orally in prediabetes. sample size are 70. Two group are selected group A and group B. In group A application of vidangadi churn 5gm Bd and in controlled group application of parijatak ghanvati. observe the result that by using vidangadi churn improvement in Hba1c or not

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
30.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patients showing sign and symptoms of prediabetic and Hba1c value between 5.7 to 6.4.

排除标准

  • IDDM patients Juvenile Diabetes Acromegaly Cushing’s syndrome pancreatic disorders Pregnancy Unconscious patients Severe gastrointestinal diseases Liver diseases tumors conditions like cardiovasculardisease acute myocardial infarction immune-compromised disease(HIV).

结局指标

主要结局

Decrease in HbA1c level

时间窗: 3 month

次要结局

  • Reduction in fatigue, naktamutrata(3 months)

研究者

发起方
VD Dnyanesh Sambhaji Deshmukh
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

VD Dnyanesh Sambhaji Deshmuukh

Ayurved Seva Sangh Ayurved Mahavidyalaya Ganeshwadi, Panchavati Nashik

研究点 (1)

Loading locations...

相似试验